An affiliate company of DFB Pharmaceuticals Inc, Healthpoint, Ltd., has signed an exclusive agreement with IsoTis, S.A. to develop and license its patented, biologic, wound-healing technology called Allox.
Highlights from AAD 2023
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
New Technology Could Allow Us to Rethink Alopecia Scores
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Pregnant Women with Skin Conditions May Require Dermatologic Intervention
Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
2 Clarke Drive Cranbury, NJ 08512